Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Sep 1;159(9):930-938.
doi: 10.1001/jamadermatol.2023.2217.

Genetic Variants Associated With Hidradenitis Suppurativa

Quan Sun  1 , K Alaine Broadaway  2 , Sharon N Edmiston  3   4 , Kristen Fajgenbaum  3 , Tyne Miller-Fleming  5 , Linnea Lackstrom Westerkam  3   6 , Maria Melendez-Gonzalez  3 , Helen Bui  7 , Franklin R Blum  6 , Brandt Levitt  8 , Lan Lin  3 , Honglin Hao  3 , Kathleen Mullan Harris  8   9 , Zhi Liu  3   4 , Nancy E Thomas  3   8 , Nancy J Cox  5 , Yun Li  1   2 , Karen L Mohlke  2 , Christopher J Sayed  3
Affiliations

Genetic Variants Associated With Hidradenitis Suppurativa

Quan Sun et al. JAMA Dermatol. .

Abstract

Importance: Hidradenitis suppurativa (HS) is a common and severely morbid chronic inflammatory skin disease that is reported to be highly heritable. However, the genetic understanding of HS is insufficient, and limited genome-wide association studies (GWASs) have been performed for HS, which have not identified significant risk loci.

Objective: To identify genetic variants associated with HS and to shed light on the underlying genes and genetic mechanisms.

Design, setting, and participants: This genetic association study recruited 753 patients with HS in the HS Program for Research and Care Excellence (HS ProCARE) at the University of North Carolina Department of Dermatology from August 2018 to July 2021. A GWAS was performed for 720 patients (after quality control) with controls from the Add Health study and then meta-analyzed with 2 large biobanks, UK Biobank (247 cases) and FinnGen (673 cases). Variants at 3 loci were tested for replication in the BioVU biobank (290 cases). Data analysis was performed from September 2021 to December 2022.

Main outcomes and measures: Main outcome measures are loci identified, with association of P < 1 × 10-8 considered significant.

Results: A total of 753 patients were recruited, with 720 included in the analysis. Mean (SD) age at symptom onset was 20.3 (10.57) years and at enrollment was 35.3 (13.52) years; 360 (50.0%) patients were Black, and 575 (79.7%) were female. In a meta-analysis of the 4 studies, 2 HS-associated loci were identified and replicated, with lead variants rs10512572 (P = 2.3 × 10-11) and rs17090189 (P = 2.1 × 10-8) near the SOX9 and KLF5 genes, respectively. Variants at these loci are located in enhancer regulatory elements detected in skin tissue.

Conclusions and relevance: In this genetic association study, common variants associated with HS located near the SOX9 and KLF5 genes were associated with risk of HS. These or other nearby genes may be associated with genetic risk of disease and the development of clinical features, such as cysts, comedones, and inflammatory tunnels, that are unique to HS. New insights into disease pathogenesis related to these genes may help predict disease progression and novel treatment approaches in the future.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Fajgenbaum reported grants from Howard H. Holderness Distinguished Medical Scholars Program (scholarship program and curriculum for UNC medical students pursuing research) during the conduct of the study. Dr Bui reported grants from National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (1R21AR075996-01A1) during the conduct of the study. Dr Cox reported grants from NIH National Human Genome Research Institute (NHGRI) during the conduct of the study. Dr Mohlke reported grants from NIH during the conduct of the study. Dr Sayed reported grants (education grant, investigator fees to institution) and personal fees (speaking, consulting) from AbbVie, grants (fees to institution as an investigator) and personal fees (speaking, consulting) from Novartis, grants and personal fees (investigator fees paid to institution) from UCB, grants (investigational fees paid to institution) and personal fees (consulting) from Incyte, grants (investigator fees paid to institution) and personal fees (consulting) from InflaRx, personal fees (consulting) from Alumis, and grants (investigator fees paid to institution) from ChemoCentryx outside the submitted work; and serving as a volunteer member of the board of the Hidradenitis Suppurativa Foundation and member of the European Hidradenitis Suppurativa Foundation. No other disclosures were reported.

Figures

Figure 1.
Figure 1.. Genetic Variants Associated With HS in a Meta-Analysis of GWAS Results From HS ProCARE, UKB, and FinnGen
Each dot corresponds to 1 variant; the x-axis indicates genomic position, and the y-axis shows the −log10(P value) of variant association with hidradenitis suppurativa (HS). Dots above the orange and blue lines show variants that reached significant (P < 5 × 10−8) and suggestive (P < 1 × 10−6) thresholds, respectively, for genome-wide association studies (GWASs). HS ProCARE indicates HS Program for Research and Care Excellence; UKB, UK Biobank.
Figure 2.
Figure 2.. HS Association Plots for 2 Loci With European LD
Variants associated with hidradenitis suppurativa (HS) in the 3-way meta-analysis located at the chromosome (chr) 17 locus (A) and the chr13 locus (B). Each point corresponds to 1 variant; the x-axis indicates genomic position, and the y-axis shows the −log10(P value) of variant association with HS, and the size of each point indicates relative sample size analyzed for that variant. Variants are colored according to their linkage disequilibrium (LD) r2 with the most significant variant in each region, which is shown as a purple diamond. The LD r2 values are based on TOPMed European-ancestry individuals. Lines point to variants located in skin enhancers (see Figure 3). The nearest protein-coding genes are not located within the 400-kilobase regions shown.
Figure 3.
Figure 3.. Candidate Genes and Regulatory Variants at 2 Hidradenitis Suppurativa Loci
Variants at the chromosome (chr) 17 locus (A) are located in an intergenic region more than 600 kb from SOX9. Among candidate variants, rs17226067, rs17825774, and rs17825799 (blue rectangle) are located in a regulatory region conserved across vertebrate species and characterized by DNase I hypersensitivity (accessible chromatin) and epigenomic marks of enhancers in NHEK epidermal keratinocytes (ENCODE consortium). Variants at the chr13 locus (B) are located in an intergenic region between KLF5 and KLF12, and candidate variant rs61957178 (blue rectangle) is located in a regulatory region characterized by epigenomic marks of enhancers in NHEK epidermal keratinocytes.
See this image and copyright information in PMC

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alikhan A, Sayed C, Alavi A, et al. . North American clinical management guidelines for hidradenitis suppurativa: a publication from the United States and Canadian Hidradenitis Suppurativa Foundations: part I: diagnosis, evaluation, and the use of complementary and procedural management. J Am Acad Dermatol. 2019;81(1):76-90. doi:10.1016/j.jaad.2019.02.067 - DOI - PMC - PubMed
    1. van Straalen KR, Prens EP, Willemsen G, Boomsma DI, van der Zee HH. Contribution of genetics to the susceptibility to hidradenitis suppurativa in a large, cross-sectional Dutch twin cohort. JAMA Dermatol. 2020;156(12):1359-1362. doi:10.1001/jamadermatol.2020.3630 - DOI - PMC - PubMed
    1. Kjaersgaard Andersen R, Clemmensen SB, Larsen LA, et al. . Evidence of gene-gene interaction in hidradenitis suppurativa: a nationwide registry study of Danish twins. Br J Dermatol. 2022;186(1):78-85. doi:10.1111/bjd.20654 - DOI - PubMed
    1. Fitzsimmons JS, Guilbert PR. A family study of hidradenitis suppurativa. J Med Genet. 1985;22(5):367-373. doi:10.1136/jmg.22.5.367 - DOI - PMC - PubMed
    1. Von Der Werth JM, Williams HC, Raeburn JA. The clinical genetics of hidradenitis suppurativa revisited. Br J Dermatol. 2000;142(5):947-953. doi:10.1046/j.1365-2133.2000.03476.x - DOI - PubMed

Publication types